BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 3, 2010
View Archived Issues
New Study Links Autophagy to Metabolic Quirks in Tumor Cells
Read More
BIO in Chicago: BioWorld Waxes Nostalgic, Biotech Perseveres
Read More
Despite Last-Minute Jitters, Pozen's Vimovo Approved
Read More
Off-Label Promotion: Filling an Unmet Need or Boosting Profit?
Read More
End of Unapproved Pancreatic Enzymes Ensures Safety: CFF
Read More
Protox's $75M Kissei Deal May Set Stage for Larger Alliances
Read More
Stock Movers
Read More
Earnings Roundup
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Bench Press
Read More
Provenge Nod Bodes Well, but No Free Pass for Cancer Vaccines
Dendreon Corp. made history last week by securing approval for Provenge (sipuleucel-T), the first therapeutic cancer vaccine ever cleared by the FDA. (BioWorld Today)
Read More
NeurogesX Pulls Down $40M Via Qutenza Deal with Cowen
Read More